| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Recruiting | Study Evaluating Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis | ||||
| Conditions: | Ankylosing Spondylitis; Arthritis, Psoriatic; Arthritis, Rheumatoid; Spondylitis, Ankylosing | |||||
| Intervention: | Drug: etanercept | |||||
| 2 | Recruiting | Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists | ||||
| Conditions: | Arthritis, Psoriatic; Psoriasis | |||||
| Intervention: | Drug: etanercept | |||||
| 3 | Recruiting | Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists | ||||
| Conditions: | Arthritis, Psoriatic; Skin Diseases, Papulosquamous; Psoriasis | |||||
| Intervention: | Drug: Etanercept | |||||
| 4 | Recruiting | Phase II Study With CC-10004 in Psoriatic Arthritis | ||||
| Condition: | Psoriatic Arthritis | |||||
| Intervention: | Drug: CC-10004 | |||||
| 5 | Recruiting | Rituxan With or Without Methotrexate in Psoriatic Arthritis | ||||
| Condition: | Psoriatic Arthritis | |||||
| Intervention: | Drug: Rituximab | |||||
| 6 | Recruiting | Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis | ||||
| Condition: | Psoriatic Arthritis | |||||
| Interventions: | Drug: Infliximab; Drug: Etanercept | |||||
| 7 | Not yet recruiting | Study Evaluating Epidemiology of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in Australia | ||||
| Conditions: | Ankylosing Spondylitis; Psoriatic Arthritis; Rheumatoid Arthritis | |||||
| Intervention: | ||||||
| 8 | Recruiting | Safety and Efficacy of Abatacept Versus Placebo in Subjects With Psoriatic Arthritis | ||||
| Condition: | Psoriatic Arthritis | |||||
| Interventions: | Drug: Abatacept; Drug: placebo | |||||
| 9 | Recruiting | Remicade® Rheumatology Registry Across Canada (Study P02843) | ||||
| Conditions: | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Psoriatic | |||||
| Intervention: | Other: Data collection post infusion | |||||
| 10 | Recruiting | Psoriasis Longitudinal Assessment and Registry (PSOLAR) | ||||
| Conditions: | Arthritis, Psoriatic; Psoriasis | |||||
| Intervention: | ||||||
| 11 | Recruiting | Study Evaluating the Safety of Enbrel (Etanercept) | ||||
| Condition: | Arthritis, Psoriatic | |||||
| Intervention: | Drug: Etanercept (Enbrel) | |||||
| 12 | Recruiting | Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (Study P04840) | ||||
| Conditions: | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Psoriatic; Psoriasis; Crohn's Disease | |||||
| Intervention: | Biological: Infliximab | |||||
| 13 | Not yet recruiting | Presence of IBD Specific Antibodies (ASCA, ALCA, ACCA, AMCA) in the Sera of Patients With Spondyloarthropathy | ||||
| Conditions: | Psoriatic Arthritis; Ankylosing Spondylitis; Undifferentiated Spondyloarthropathy | |||||
| Intervention: | ||||||
| 14 | Recruiting | Centocor Microarry Study of Patients | ||||
| Conditions: | Rheumatoid Arthritis; Psoriatic Arthritis; Psoriasis; Crohn's Disease | |||||
| Intervention: | Drug: Infliximab | |||||
| 15 | Recruiting | Phase 2, Open-Label Study to Evaluate CC-10004 Recalcitrant (Not Responded to Therapy) Plaque-Type Psoriasis | ||||
| Conditions: | Recalcitrant Psoriasis; Refractory Psoriasis | |||||
| Intervention: | Drug: CC-10004 | |||||
| 16 | Not yet recruiting | A Phase 3 Trial to Look at the Safety and Effectiveness of Ustekinumab in Korean and Taiwanese Subjects With Moderate to Severe Plaque-Type Psoriasis | ||||
| Condition: | Psoriasis | |||||
| Intervention: | Drug: CNTO 1275; Ustekinumab | |||||
| 17 | Recruiting | Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis | ||||
| Condition: | Arthritis | |||||
| Intervention: | Biological: Quadrivalent HPV vaccine (Gardasil®) | |||||
|
